Press "esc" to clear
Go to Advanced Search

Showing results

5160 of 4910
pacman_laura_chamblis_studio_yopp-SFI.jpg
  • Embargo expired:
    13-Feb-2018 5:00 AM EST

Article ID: 689277

When It Comes to Extinction Risk, Body Size Matters

Santa Fe Institute

Models for extinction risk are necessarily simple. Most reduce complex ecological systems to a linear relationship between resource density and population growth—something that can be broadly applied to infer how much resource loss a species can survive.

Released:
9-Feb-2018 11:00 AM EST
EXPERT AVAILABLE
Add to Favorites
Comment

Channels:

All Journal News, Evolution and Darwin, Nature (journal), Cell Biology, Environmental Science, Wildlife

  • Embargo expired:
    13-Feb-2018 12:05 AM EST

Article ID: 689418

Cabozantinib Shows Significant Activity in the First Line for Differentiated Thyroid Cancer

American Society for Radiation Oncology (ASTRO)

Results of a new phase II clinical trial indicate that cabozantinib offers an active therapy option for patients with differentiated thyroid cancer (DTC) that has progressed following surgery and treatment with radioactive iodine (RAI). Thirty-four of 35 patients in the trial experienced a reduction in tumor size following treatment with the targeted kinase inhibitor, and more than half experienced reductions in excess of 30 percent.

Released:
13-Feb-2018 7:05 AM EST
EXPERT AVAILABLE
Add to Favorites
Comment

Channels:

All Journal News, Cancer, Cell Biology, Local - Virginia

hCA_overall.png

Article ID: 689374

Neutron Study of Glaucoma Drugs Offers Clues About Enzyme Targets for Aggressive Cancers

Oak Ridge National Laboratory

A team of researchers from ORNL’s Energy and Transportation Science Division is using neutron imaging to study particulate filters that collect harmful emissions in vehicles. A better understanding of how heat treatments and oxidation methods can remove layers of soot and ash from these filters could lead to improved fuel-efficiency.

Released:
12-Feb-2018 1:05 PM EST
EXPERT AVAILABLE
Add to Favorites
Comment

Channels:

All Journal News, Cancer, Cell Biology, Pharmaceuticals, Women's Health, DOE Science News, Energy

Lu_CancerCell_MPNSTSNF.jpg
  • Embargo expired:
    12-Feb-2018 12:00 PM EST

Article ID: 689152

Study Suggests Way to Attack Deadly, Untreatable Nerve Tumors

Cincinnati Children's Hospital Medical Center

Genomic profiling of mostly untreatable and deadly nerve sheath tumors led scientists to test a possible therapeutic strategy that inhibited tumor growth in lab tests on human tumor cells and mouse models, according to research in the journal Cancer Cell.

Released:
7-Feb-2018 1:15 PM EST
EXPERT AVAILABLE
Add to Favorites
Comment
Hung_Mien_Chie2.jpg
  • Embargo expired:
    12-Feb-2018 12:00 PM EST

Article ID: 689298

Newly Identified Potential Therapeutic Approach Kills Triple-Negative Breast Cancer Cells in Pre-Clinical Study

University of Texas M. D. Anderson Cancer Center

Triple-negative breast cancer (TNBC), a highly aggressive, relapse-prone cancer that accounts for one-fourth of all breast cancers, could be the focus of a new area of study for immune checkpoint blockade therapy. A team of researchers at The University of Texas MD Anderson Cancer Center revealed that in TNBC a cell process called glycosylation is required for PD-L1/PD1 molecules to interact and identified exactly how and why glycosylation is so crucial.

Released:
9-Feb-2018 12:00 PM EST
EXPERT AVAILABLE
Add to Favorites
Comment

Channels:

All Journal News, Cancer, Cell Biology, Immunology, Women's Health, Local - Texas, Local - Houston Metro

Article ID: 689363

Researchers Inhibit Cancer Metastases via Novel Steps

Case Western Reserve University

In one of the first successes of its kind, researchers have inhibited the spreading of cancer cells from one part of the body to another. In doing so, they relied on a new model of how cancer metastasizes that emphasizes epigenetics, which examines how genes are turned on and off.

Released:
12-Feb-2018 11:05 AM EST
EXPERT AVAILABLE
Add to Favorites
Comment
LuNatureMedicine.jpg
  • Embargo expired:
    12-Feb-2018 11:00 AM EST

Article ID: 689208

Experimental Therapy Restores Nerve Insulation Damaged by Disease

Cincinnati Children's Hospital Medical Center

When the body attacks its own healthy tissues in an autoimmune disease, peripheral nerve damage handicaps people and causes persistent neuropathic pain when insulation on healing nerves doesn’t fully regenerate. Unfortunately, there are no effective ways to treat the condition. Now scientists describe in Nature Medicine an experimental molecular therapy that restores insulation on peripheral nerves in mice, improves limb function, and results in less observable discomfort.

Released:
8-Feb-2018 11:30 AM EST
EXPERT AVAILABLE
Add to Favorites
Comment

Channels:

All Journal News, Autoimmune Diseases, Children's Health, Mental Health, Neuro, Cancer, Cell Biology, Nature (journal), Local - Ohio

Article ID: 689287

Biomarker Predicts Success of Afib Treatment

Johns Hopkins Medicine

Johns Hopkins researchers report successful use of heart imaging to predict the benefit or futility of catheter ablation, an increasingly popular way to treat atrial fibrillation, a common heart rhythm disorder.

Released:
12-Feb-2018 8:00 AM EST
EXPERT AVAILABLE
Add to Favorites
Comment

Channels:

All Journal News, Grant Funded News, Cardiovascular Health, Heart Disease, Cell Biology, Chemistry, Local - Maryland

  • Embargo expired:
    10-Feb-2018 1:10 PM EST

Article ID: 688935

New Immunotherapy Combination Tolerable, Effective in Patients with Advanced Kidney Cancer

Georgetown Lombardi Comprehensive Cancer Center

Combining an anti-angiogenesis agent, which blocks blood vessel formation, with an immunotherapy agent, was found to have promising anti-tumor activity and no unexpected side effects in an early-phase clinical trial in patients with advanced kidney cancer.

Released:
8-Feb-2018 7:05 AM EST
EXPERT AVAILABLE
Add to Favorites
Comment

Channels:

All Journal News, Blood Disorders, Cancer, Cell Biology, Immunology, Local - DC, Local - DC Metro

Article ID: 668302

Modified Drug Shows Promise, Patterns in Vietnam, Phone-Delivered Therapy, and More in the AIDS and HIV News Source

Newswise

The latest research, features, and experts on HIV and AIDS.

Released:
9-Feb-2018 4:50 PM EST
EXPERT AVAILABLE
Add to Favorites
Comment

Channels:

AIDS and HIV, Autoimmune Diseases, Behavioral Science, Biotech, Bone Health, Cell Biology, Chemistry, Children's Health, Infectious Diseases, Men's Health, Mental Health, Military Health, Public Health, Regenerative Medicine, Seniors, Sex and Relationships, Sleep, Stem Cells, Women's Health, Local - Virginia


Showing results

5160 of 4910





Chat now!